The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksASLR.L Regulatory News (ASLR)

  • There is currently no data for ASLR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Placing and Change of Website Address

8 Jan 2020 07:00

RNS Number : 0638Z
Asimilar Group PLC
08 January 2020
 

 

Asimilar Group plc

("Asimilar" or the "Company")

£6.8 million Equity Placing at 40 pence per share with Warrants

Asimilar Group Plc, the AIM quoted investment company focused on technology opportunities in the fields of big data, machine learning, telematics and the Internet of Things (IoT), is pleased to announce that it has raised £6.8 million (gross) of new equity by way of a placing (the "Placing") of 17,000,000 new Ordinary Shares in the Company (the "Placing Shares") at a price of 40 pence per Ordinary Share with existing and new investors.

A warrant will be issued for every Placing Share subscribed for as part of the Placing exercisable at 130 pence per Ordinary Share from the date of issue up to 31 December 2021 ("Warrant"), with an accelerated exercise provision in the event that the mid-market price for Asimilar's Ordinary Shares reaches 280 pence per Ordinary Share for 5 consecutive business days. The Warrants will be required to be exercised within 21 calendar days of such an event or otherwise will lapse. Exercise of all the Warrants in the Company issued as part of the Placing would raise a further £22.1 million for the Company.

Investors that have committed to subscribe for Placing Shares include Nigel Wray and Chris Akers.

The proceeds of the Placing (after expenses) will be used, in conjunction with the funds currently held by Asimilar, to pursue the Company's investing policy of focusing on technology opportunities in the fields of big data, machine learning, telematics and the internet of things. The Company is currently actively considering a number of potential investment opportunities some of which may, or may not, lead to a reverse takeover at some time in the future.

Following completion of the Placing, Asimilar expects to have net cash available for investment of approximately £9.3 million.

The Placing will complete in 2 tranches, the first of which will complete on or around Friday 24 January 2020 and the second will complete on or around 13 March 2020.

Tranche 1

The £4,000,000 subscription monies payable for 10,000,000 of the Placing Shares ("Tranche 1 Placing Shares") are payable on 24 January 2020. Application will be made to the London Stock Exchange for the Tranche 1 Placing Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission of the Tranche 1 Placing Shares will become effective on or around 24 January 2020. 

Tranche 2

The £2,800,000 subscription monies payable for 7,000,000 of the Placing Shares ("Tranche 2 Placing Shares") are payable on 13 March 2020. Application will be made for admission of the Tranche 2 Placing Shares and it is expected that admission of the Tranche 2 Placing Shares will become effective on or around 13 March 2020.

All the Placing Shares will rank pari passu with the Company's existing Ordinary Shares in all respects.

Total Voting Rights

The current issued share capital of the Company is 82,132,276 Ordinary Shares, each with voting rights. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the Disclosure and Transparency Rules.

Following the admission of the 11,562,500 Ordinary Shares issued pursuant to the placing announced on 18 December 2019 on or around 20 January 2020, the total issued share capital of the Company will be 93,694,776 Ordinary Shares, each with voting rights.

Following the admission of the 10,000,000 Tranche 1 Placing Shares on or around 24 January 2020, the total issued share capital of the Company will be 103,694,776 Ordinary Shares, each with voting rights.

Following the admission of the 7,000,000 Tranche 2 Placing Shares on or around 13 March 2020, the total issued share capital of the Company is expected to be 110,694,776 Ordinary Shares, each with voting rights.

As part of the Placing, Nigel Wray, who currently holds 12.19% of the issued share capital in the Company, has subscribed for 1,875,000 Ordinary Shares. Following admission of the Tranche 1 Placing Shares, he will hold approximately 11.5% of the issued share capital. Nigel Wray's participation in the Placing is considered to be a related party transaction under the AIM Rules for Companies. The Directors, having consulted with the Company's Nominated Adviser, consider that the terms of the participation of Mr Wray in the Placing are fair and reasonable insofar as the Company's shareholders are concerned.

New Website

Following the change of name announced on 23 December 2019, the Company's website address has been changed to www.asimilargroup.com.

 

John Taylor, Chairman of the Company said:

"We are excited by this premium equity placing which facilitates considerably greater capital flexibility for Asimilar to pursue a select number of potentially bold and transformative investment options. We look forward to keeping shareholders updated on our progress over the coming period".

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

**ENDS**

Enquiries

Asimilar Group plc

 

John Taylor, Non-Executive Chairman

via Wallbrook

 

 

Cairn Financial Advisers LLP

 

Sandy Jamieson, Liam Murray

Tel: +44 20 7213 0880

 

 

Peterhouse Capital Limited

 

Duncan Vasey / Lucy Williams

Tel: + 44 20 7220 9797

 

 

Walbrook PR Ltd

Tel: +44 20 7933 8787

Paul McManus

Mob: +44 7980 541 893

Nick Rome

Mob: +44 7748 325 236

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCKDLFBBFLEBBK
Date   Source Headline
1st Apr 20213:58 pmRNSExercise of Warrants
31st Mar 20216:04 pmRNSExtension of Warrant Exercise Date
30th Mar 20217:00 amRNSAnnual Report and Accounts and Portfolio Update
29th Mar 20215:32 pmRNSExercise of Warrants & Vesting of Warrants
26th Mar 20213:36 pmRNSExercise of Warrants
22nd Mar 20211:17 pmRNSHolding(s) in Company
18th Mar 20217:00 amRNSCompletion of Subscription
9th Mar 20212:06 pmRNSUpdate re MESH
1st Mar 202111:02 amRNSDev Clever Subscription
25th Feb 20217:00 amRNSAssignment of Subscription Rights
17th Feb 20214:29 pmRNSExercise of Warrants
15th Feb 202111:35 amRNSAnnouncement of Agreement by MESH re Sentiance
27th Jan 20217:00 amRNSUpdate re: Dev Clever Subscription Rights
26th Jan 20217:00 amRNSUpdate re subscription in Dev Clever
18th Jan 20219:51 amRNSExercise of Warrants
13th Jan 20218:28 amRNSExercise of Warrants
12th Jan 20214:41 pmRNSSecond Price Monitoring Extn
12th Jan 20214:35 pmRNSPrice Monitoring Extension
31st Dec 20207:00 amRNSFurther Equity Investment in SeeQuestor
21st Dec 20207:30 amRNSStatement re Announcement by Dev Clever
17th Dec 20207:00 amRNSDirector's Disclosure
7th Dec 20207:00 amRNSFurther Investment in Magic Media Works
1st Dec 20207:00 amRNSFurther conditional investment in Dev Clever
30th Nov 20204:08 pmRNSAssignment of Sentiance Loan
24th Nov 20207:00 amRNSDirector's Dealing
9th Nov 20202:49 pmRNSUpdate re Magic Media Works Limited
9th Nov 20207:00 amRNSFurther Investment in SeeQuestor
2nd Nov 20207:00 amRNSUpdate re Dev Clever Subscription Rights
26th Oct 202011:21 amRNSResult of AGM
23rd Oct 20207:00 amRNSExercise of Warrants
20th Oct 20207:00 amRNSAward of Warrants to Director
7th Oct 20204:40 pmRNSSecond Price Monitoring Extn
7th Oct 20204:35 pmRNSPrice Monitoring Extension
7th Oct 20202:05 pmRNSSecond Price Monitoring Extn
7th Oct 20202:00 pmRNSPrice Monitoring Extension
30th Sep 20207:00 amRNSNotice of AGM & Update re Loan to Sentiance
29th Sep 20203:18 pmRNSHolding(s) in Company
23rd Sep 20203:24 pmRNSBoard Changes
16th Sep 202012:57 pmRNSExercise of Warrants
10th Sep 202012:00 pmRNSUpdate re: Dev Clever Holdings plc
8th Sep 20202:39 pmRNSMarket Update
7th Sep 20207:00 amRNSHolding(s) in Company
3rd Sep 20207:00 amRNSExercise of Subscription rights
1st Sep 20207:00 amRNSAcquisition of Intrinsic Capital (Jersey) Ltd
1st Sep 20207:00 amRNSUpdate to Right to Subscribe
25th Aug 20207:30 amRNSRestoration - Asimilar Group plc
25th Aug 20207:00 amRNSCompletion of Agreement & Lifting of Suspension
20th Aug 202011:29 amRNSMESH AGM
3rd Aug 20203:12 pmRNSAgreement with MESH Holdings plc
31st Jul 202012:14 pmRNSUpdate re. Suspension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.